Sun Pharma recalls its drug in the US

The Pharma giant recalls 68,194 bottles of its anti-depression drug in the US

recall1-1-jpg-475x310-q85

The company is recalling the drug for failing dissolution specification

Sun Pharma has decided to recall 68,194 bottles of its Venlafaxine Hydrochloride Extended-Release tablets, an anti-depression in the US. The company is recalling the drug for failing "dissolution specification". The 37.5 mg tablets in 30-count bottles and 90-count bottles, were manufactured by Sun Pharmaceutical Industries at Halol for Sun Pharma Global, Dubai.

The withdrawal was classified as a Class-II recall, which the FDA defines as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

 

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X